Jeffrey E. Russel

Array ( [id] => 6131260 [patent_doc_number] => 20020077282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'METHOD FOR TREATING CYSTIC FIBROSIS' [patent_app_type] => new [patent_app_number] => 09/226666 [patent_app_country] => US [patent_app_date] => 1999-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4215 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077282.pdf [firstpage_image] =>[orig_patent_app_number] => 09226666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890622 [patent_doc_number] => 20010007853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'METHOD FOR ADMINISTERING MONOMERIC INSULIN ANALOGS' [patent_app_type] => new-utility [patent_app_number] => 09/226420 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6466 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007853.pdf [firstpage_image] =>[orig_patent_app_number] => 09226420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174232 [patent_doc_number] => 06083909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers' [patent_app_type] => 1 [patent_app_number] => 9/214430 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4968 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083909.pdf [firstpage_image] =>[orig_patent_app_number] => 214430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118216 [patent_doc_number] => 06071881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Peptides and remedy for bone diseases containing the same as active ingredient' [patent_app_type] => 1 [patent_app_number] => 8/930776 [patent_app_country] => US [patent_app_date] => 1999-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2295 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071881.pdf [firstpage_image] =>[orig_patent_app_number] => 930776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4229152 [patent_doc_number] => 06165458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Composition and method for dermal and transdermal administration of a cytokine' [patent_app_type] => 1 [patent_app_number] => 9/216500 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 7536 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165458.pdf [firstpage_image] =>[orig_patent_app_number] => 216500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290695 [patent_doc_number] => 06211333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secreted from the hypothalamus' [patent_app_type] => 1 [patent_app_number] => 9/202621 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11349 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211333.pdf [firstpage_image] =>[orig_patent_app_number] => 202621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248595 [patent_doc_number] => 06221836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal' [patent_app_type] => 1 [patent_app_number] => 9/213968 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7863 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221836.pdf [firstpage_image] =>[orig_patent_app_number] => 213968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1581516 [patent_doc_number] => 06423689 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Peptidyl calcium channel blockers' [patent_app_type] => B1 [patent_app_number] => 09/212785 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 42857 [patent_no_of_claims] => 146 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423689.pdf [firstpage_image] =>[orig_patent_app_number] => 09212785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125863 [patent_doc_number] => 06120761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Erythropoietin solution preparation' [patent_app_type] => 1 [patent_app_number] => 9/171737 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3262 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120761.pdf [firstpage_image] =>[orig_patent_app_number] => 171737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4081910 [patent_doc_number] => 06054428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Eutrophic drug compositions based on transferrin glycans' [patent_app_type] => 1 [patent_app_number] => 9/208593 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3672 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054428.pdf [firstpage_image] =>[orig_patent_app_number] => 208593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096193 [patent_doc_number] => 06096709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Use of angiotensin II fragments and analogs thereof in tissue repair' [patent_app_type] => 1 [patent_app_number] => 9/208337 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7558 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096709.pdf [firstpage_image] =>[orig_patent_app_number] => 208337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407288 [patent_doc_number] => 06172038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Antipathogenic peptides and compositions comprising them' [patent_app_type] => 1 [patent_app_number] => 9/125605 [patent_app_country] => US [patent_app_date] => 1998-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 30 [patent_no_of_words] => 20176 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172038.pdf [firstpage_image] =>[orig_patent_app_number] => 125605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416608 [patent_doc_number] => 06177059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'GPIb-lipid complex and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/117746 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5058 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177059.pdf [firstpage_image] =>[orig_patent_app_number] => 117746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109747 [patent_doc_number] => 06045818 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Cell growth substrates with tethered cell growth effector molecules' [patent_app_type] => 1 [patent_app_number] => 9/200493 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7416 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/045/06045818.pdf [firstpage_image] =>[orig_patent_app_number] => 200493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4206042 [patent_doc_number] => 06077829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Stable pharmaceutical composition of BDNF' [patent_app_type] => 1 [patent_app_number] => 9/180884 [patent_app_country] => US [patent_app_date] => 1998-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4954 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077829.pdf [firstpage_image] =>[orig_patent_app_number] => 180884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1457725 [patent_doc_number] => 06391300 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation' [patent_app_type] => B1 [patent_app_number] => 09/192905 [patent_app_country] => US [patent_app_date] => 1998-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 26 [patent_no_of_words] => 10016 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391300.pdf [firstpage_image] =>[orig_patent_app_number] => 09192905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101123 [patent_doc_number] => 06066618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Regulation of cell proliferation and differentiation using peptides' [patent_app_type] => 1 [patent_app_number] => 9/191192 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6605 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066618.pdf [firstpage_image] =>[orig_patent_app_number] => 191192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1329473 [patent_doc_number] => RE038158 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Adhesive sealant composition' [patent_app_type] => E1 [patent_app_number] => 09/185732 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8146 [patent_no_of_claims] => 154 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038158.pdf [firstpage_image] =>[orig_patent_app_number] => 09185732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295247 [patent_doc_number] => 06197751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Thymosin .alpha.1 promotes tissue repair, angiogenesis and cell migration' [patent_app_type] => 1 [patent_app_number] => 9/186476 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 21 [patent_no_of_words] => 12084 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197751.pdf [firstpage_image] =>[orig_patent_app_number] => 186476 [rel_patent_id] =>[rel_patent_doc_number] =>)